In China, influenza A(H7N9) virus appeared in 2013, then mutated into a highly pathogenic virus, causing outbreaks among poultry and cases in humans. Since September 2017, extensive use of the corresponding vaccine, H7-Re1, successfully reduced virus prevalence. However, in 2019, a novel antigenic variant emerged, posing considerable economic and public health threats.

Read more at CDC…

The post Antigenic Variant of Highly Pathogenic Avian Influenza A(H7N9) Virus, China, 2019 appeared first on Healthier Environment Living Program.